$DMAA

$10.87 -$0.01 (0.09%) Close

$DMAA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 24.3M shares outstanding

Who owns DMAA?

By type of holder

Institutions 54.9% Insiders 0.0% Everyone else 45.2%

Concentration Top 10 holders own 82.8%

Lynn Stockwell 17.3% · Drugs Made In America Acquisition LLC 17.3%

Institutional ownership

54.9%

-39.4 pts vs last qtr

Institutional holders

-17 vs last qtr

Net shares bought

−9.6M

by institutions in Q2 2026

New / sold out

1 / 18

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Mizuho Securities USA LLC +2.1M
Logan Stone Capital, LLC NEW +110.0K

Biggest sellers in Q2 2026

First Trust Capital Management L.P. −1.5M
Westchester Capital Management, LLC −1.1M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Drugs Made In America Acquisition Corp. in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Drugs Made In America Acquisition Corp..

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years86% Under 1 year14%

Quarterly turnover

30.5%

of institutional shares changed hands

Top 10 managers, median time held

1.3 years

Super Investors

Investment managers reporting DMAA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MS Mizuho Securities USA LLC	4.1M	16.76%	+2.1M (+103.5%)	2025	0.4%
Shares held by quarter Peak holding4.1M (Q2'26) Change over 8 quarters+4.1M Share of the company16.760% Mizuho Securities USA LLC's full portfolio →
KM Karpus Management, Inc.	2.5M	10.33%	−22.7K (−0.9%)	2025	0.8%
Shares held by quarter Peak holding2.7M (Q2'25) Change over 8 quarters+2.5M Share of the company10.330% Karpus Management, Inc.'s full portfolio →

Mizuho Securities USA LLC

4.1M

% of company

16.76%

Change vs last qtr

+2.1M (+103.5%)

Held since

2025

Karpus Management, Inc.

2.5M

% of company

10.33%

Change vs last qtr

−22.7K (−0.9%)

Held since

2025

25 more super investors behind a free account

See every manager holding Drugs Made In America Acquisition Corp., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DMAA on Form N-PORT; together they hold 3.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FT First Trust Merger Arbitrage Fund Investment Managers Series Trust II	$7.19M	675.4K	2.78%	0.44%	June 30, 2026
FT First Trust Multi-Strategy Fund Investment Managers Series Trust II	$1.12M	105.1K	0.43%	0.08%	June 30, 2026

First Trust Merger Arbitrage Fund

Investment Managers Series Trust II

Position value

$7.19M

% of company

2.78%

% of the fund

0.44%

As of

June 30, 2026

First Trust Multi-Strategy Fund

Investment Managers Series Trust II

Position value

$1.12M

% of company

0.43%

% of the fund

0.08%

As of

June 30, 2026

1 more funds behind a free account

See every fund holding Drugs Made In America Acquisition Corp. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LS Lynn Stockwell 5%+ holder 13D · 12.5%	4.2M	17.25%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company17.250% Disclosed stake13D · 12.5% View the 13D/G filing →
DM Drugs Made In America Acquisition LLC 5%+ holder 13D · 12.5%	4.2M	17.25%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company17.250% Disclosed stake13D · 12.5% View the 13D/G filing →

Lynn Stockwell

5%+ holder13D · 12.5%

4.2M

% of company

17.25%

Change vs last qtr

—

Held since

—

Drugs Made In America Acquisition LLC

5%+ holder13D · 12.5%

4.2M

% of company

17.25%

Change vs last qtr

—

Held since

—

Comments